Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends
Biomedical Engineering Letters
;
(4): 359-366, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-785517
ABSTRACT
Photobiomodulation (PBM) is a rapidly growing as an innovative therapeutic modality for various types of diseases in recent years. Neuronal degeneration is irreversible process and it is proven to be difficult to slow down or stop the progression. Pharmacologic approaches to slow neuronal degeneration have been studied, but are limited due to concerns about the side effects. Therefore, it is necessary to develop a new therapeutic approach to stabilize neuronal degeneration and achieve neuronal protection against several neurodegenerative diseases. In this review, we have introduced several previous studies showing the positive effect of PBM over neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and different types of epilepsy. Despite excellent outcomes of animal researches, not many clinical studies are conducted or showed positive outcome of PBM against neurodegenerative disease. To achieve clinical application of PBM against neurodegenerative disorder, determination of exact mechanism and establishment of effective clinical protocol seems to be necessary.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Enfermedad de Parkinson
/
Protocolos Clínicos
/
Enfermedades Neurodegenerativas
/
Experimentación Animal
/
Epilepsia
/
Enfermedad de Alzheimer
/
Neuroprotección
/
Neuronas
Tipo de estudio:
Guía de Práctica Clínica
Idioma:
Inglés
Revista:
Biomedical Engineering Letters
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS